Literature DB >> 16741317

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Lalitha K Shankar1, John M Hoffman, Steve Bacharach, Michael M Graham, Joel Karp, Adriaan A Lammertsma, Steven Larson, David A Mankoff, Barry A Siegel, Annick Van den Abbeele, Jeffrey Yap, Daniel Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16741317

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  262 in total

1.  Medical imaging in new drug clinical development.

Authors:  Yi-Xiang Wang; Min Deng
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

2.  Variability in PET quantitation within a multicenter consortium.

Authors:  Frederic H Fahey; Paul E Kinahan; Robert K Doot; Mehmet Kocak; Harold Thurston; Tina Young Poussaint
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

3.  A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.

Authors:  Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Ron Epelbaum; Irit Avivi; Menachem Ben-Shachar; Diana Gaitini; Jacob M Rowe
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

Review 4.  Machine learning in quantitative PET: A review of attenuation correction and low-count image reconstruction methods.

Authors:  Tonghe Wang; Yang Lei; Yabo Fu; Walter J Curran; Tian Liu; Jonathon A Nye; Xiaofeng Yang
Journal:  Phys Med       Date:  2020-07-29       Impact factor: 2.685

5.  Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.

Authors:  An-Na Tong; Shao-Rong Han; Peng Yan; Hai Gong; Hui Zhao; Hui Yao; Yan-Ming Wang
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

6.  Scanning linear estimation: improvements over region of interest (ROI) methods.

Authors:  Meredith K Kupinski; Eric W Clarkson; Harrison H Barrett
Journal:  Phys Med Biol       Date:  2013-02-06       Impact factor: 3.609

7.  A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.

Authors:  Robert L Harrison; Brian F Elston; Robert K Doot; Thomas K Lewellen; David A Mankoff; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

8.  Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection.

Authors:  Hua-Xiang Xu; Tao Chen; Wen-Quan Wang; Chun-Tao Wu; Chen Liu; Jiang Long; Jin Xu; Ying-Jian Zhang; Run-Hao Chen; Liang Liu; Xian-Jun Yu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-13       Impact factor: 9.236

9.  Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.

Authors:  Janet F Eary; Ernest U Conrad; Janet O'Sullivan; Douglas S Hawkins; Scott M Schuetze; Finbarr O'Sullivan
Journal:  J Bone Joint Surg Am       Date:  2014-01-15       Impact factor: 5.284

10.  PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study.

Authors:  Christelle Tychyj-Pinel; Fabien Ricard; Michael Fulham; Marion Fournier; Michel Meignan; Thierry Lamy; Pierre Vera; Gilles Salles; Judith Trotman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.